Background Hypertension affects up to 5 % of all children, but little is known about the role of medication adherence on blood pressure (BP) control. In this study we examined the association between adolescents' antihypertensive medication adherence and BP control, investigating for racial disparities. Methods A total of 21 adolescents with essential hypertension [mean age 14.7 ± 2.0 years, 57 % male, 52 % African American] were recruited from a pediatric nephrology clinic. Objective medication adherence measures were obtained with Medication Event Monitoring System (MEMS) caps and pharmacy refill records to determine medication possession ratios (MPRs). Results The African Americans adolescents had lower medication adherence than non-African Americans adolescents based on the MPR over the past 12 months (mean 0.54± 0.21 vs. 0.85±0.16, respectively; p<0.001) and a trend for less adherence measured by MEMS caps over the last 28 days (mean 0.75 ±0.26 vs. 0.91± 0.04, respectively; p<0.07). Seven of the eight participants with low adherence (MPR<0.65) had uncontrolled BP (systolic and/or diastolic BPs≥95th percentile), and no participants with high adherence according to the MPR had uncontrolled BP (p<0.001). There was no difference in BP control by race.
Introduction
The prevalence of hypertension in children and adolescents is increasing [1, 2] . Recent estimates show that hypertension affects approximately 3.2-4.5 % of all children [3, 4] . Hypertension in children and adolescents is linked to targetorgan damage, including left ventricular hypertrophy, microalbuminuria, increased carotid intima-media thickness [5] , and renal disease progression [6] . Longitudinal studies show that high blood pressure (BP) in children and adolescents confers a higher risk of hypertension as an adult [7] .
Antihypertensive medications have been shown to not only reduce BP, but also to reduce/regress target-organ damage [8] . Despite these health benefits, non-adherence to antihypertensive medications is common among adults with hypertension. A recent review of chronic medication adherence among 706,032 adults found that 28 % of patients on antihypertensive medications were less than 80 % adherent [9] . Non-adherence has also been reported among adolescents: a single-center cohort of adolescent patients with primary hypertension found that poor BP control in at least half of the treated patients was due to self-reported nonadherence to medication [10] .
Ethnic minority populations have disproportionately high rates of poor BP control. Among adult populations, African Americans have earlier onset of hypertension, higher prevalence, and worse control and are more likely to experience end-organ damage compared to white adults [11] [12] [13] [14] . A study of cardiovascular functioning of racially and socioeconomically diverse healthy adolescents found that an individual's race predicted elevated BP measurements as well as greater BP reactivity to stressors [14] . Factors that have been shown to contribute to this disparity among adults include reporting antihypertensive medication nonadherence and an increased number of medication side effects [15] . However, little information is known about the racial disparities in BP control or medication adherence among adolescents with hypertension.
The aims of this pilot study were to obtain preliminary estimates of adolescents' objectively measured adherence, as well as parent-and self-reported adherence, to antihypertensive medications and examine the associations of adherence, or lack thereof, with BP control and race. We hypothesized that medication adherence would be associated with BP control such that adolescents with high adherence would be more likely to have their well-controlled BP. We also hypothesized that African American adolescents would be more likely to have lower medication adherence and worse blood pressure control than non-African American adolescents.
Methods

Study design
This was an observational study of children recruited from the Johns Hopkins University Harriet Lane Kidney Center, which is a general pediatric nephrology clinic that treats children from birth through to age 22 years. The Johns Hopkins Medical Institutions Institutional Review Board reviewed and approved this study. Written informed consent was obtained from each adolescent's primary caregiver, and written assent was obtained by the adolescent prior to baseline assessment. Trained research assistants conducted all assessment visits with participants either at the clinic or the participant's home. Families who agreed to participate underwent three study visits either at their home or during their scheduled nephrology clinic visit.
At the first visit, a research assistant placed one of the participant's antihypertensive medications in a bottle that was fitted with a Medication Event Monitoring System (MEMS) cap. Due to cost only one of the patient's prescribed antihypertensive medications was monitored with a MEMS cap. The family was instructed in the proper use of the MEMS cap and informed that the cap recorded the time and date when the bottle was opened as an indication of when the medication was taken. Two subsequent visits were completed approximately 2 weeks apart in order to retrieve the MEMS cap data and complete a debriefing interview on the family's experience with the MEMS cap. The goal was to collect at least 28 days of data. Caregivers provided the name and contact information for all pharmacies they used to obtain antihypertensive medications in the previous 12 months. Each pharmacy was faxed an introductory letter requesting refill records along with a copy of the patient's signed consent form. Pharmacies were pursued until all records were received.
Participants
Eligibility criteria were as follows: adolescents aged 11-17 years who had a diagnosis of essential hypertension and were currently prescribed antihypertensive medication. Eighty five adolescents were identified and were sent a letter from the clinic director with information about the study. Patients were informed that if they were not interested in the study they could call the study coordinator and opt out. No patient used this option. Fifty-nine families were contacted by phone due to geographical proximity. Fifty-one families were screened to confirm eligibility (4 families refused and for 4 families we had wrong numbers), and the parent(s) and adolescent of these families received a more detailed description of the study; if interested, a first visit was scheduled. Among the screened participants, 32 were eligible (reasons for ineligibility: 8 were not prescribed antihypertensive medication, 2 did not live in the state, 2 did not speak English, 2 had developmental delay, 4 were not interested, and 1 child was too old), and visits were completed with 22 participants (reasons for non-completion: 1 was no longer prescribed medication, 8 could not be contacted, 1 was not interested). Two of the 22 families interested in participation contacted the office; their adherence was not different than that of the other recruited participants. Participants did not differ from non-participants by age, gender, BP percentile, and race.
Measures
MEMS ratio
The MEMS cap is an electronic monitor that records the date and time of pill bottle opening. A mean MEMS ratio was calculated by using the number of cap-opening events during the 28-day monitoring period as the numerator and the number of doses prescribed for the same period as the denominator. Due to cost limitation, only one antihypertensive medication was monitored.
Medication possession ratio Pharmacy refill records were used to calculate the medication possession ratio (MPR), defined as the sum of all days of medication supply received divided by the number of days the medication was prescribed during the study period [16] . MPRs were calculated for each of the targeted medications individually with values truncated to 100 %. The MPRs of each medication for the past 12 months were averaged across all hypertension medications to obtain the composite MPR. If an individual was prescribed only one drug, then the composite MPR is equal to his or her MPR for that individual drug.
Medication Adherence Measure Parents and teens both completed the 8-item Medication Adherence Measure developed by Morisky et al. [17] at the end of MEMS monitoring during visit 3. This measure asks patients about specific behaviors that may interfere with their ability to regularly take medication such as "do you sometimes have problems remembering to take your medication?" The selfreport version was modified for the parents so that parents reported on their teen's adherence. Response categories are scored yes/no for the first seven items, and a 5-point Likert response is used for the last item. In order to account for missing data a ratio of the sum of responses divided by total items answered was created such that higher scores indicated more no-adherent behavior.
Health outcome information Health outcome information, including BP measurements, comorbidities, height, weight, and prescribed treatment regimen information was abstracted from the participant's medical record from their last clinic visit. All blood pressures were measured by manual auscultation according to published guidelines [18] . Patients were considered to have their BP under control if their systolic and diastolic BP was below their age-, sex-and height-specific 95th percentile BP. Children with either a systolic or diastolic BP at or above their 95th percentile BP at the most recent clinic visit were considered to have poor BP control [18] .
Statistical analyses
Descriptive frequencies of sociodemographic characteristics were generated using means and proportions as appropriate. To determine how well the different measures of adherence correlated with each other, we constructed a correlation matrix with values closer to either −1 or +1 indicating good agreement and 0 indicating poor agreement. Statistical comparisons between groups were made using Fisher's exact tests for categorical data. Because there is no standard definition of adherence based across all measures, we used each measure's median to divide participants into two groups: a low and high adherence group, respectively. To examine differences in blood pressure control by adherence a median split was conducted at the following cutoff points for each measure: MPR=0.65, MEMs ratio=0.89, and parent/teen report=0.5. The SAS ver. 9.2 program (SAS Institute, Cary, NC) was used for all statistical analyses. P values of <0.05 were considered to be statistically significant.
Results
Sample characteristics
A total of 22 adolescents and their parents consented to join the study. One participant did not complete any follow-up visits, resulting in a final sample of 21 participants. A total of ten (48 %) were African American, while 11 (52 %) were non-African American. Included in the non-African American group were children who reported their race as white or Asian. Table 1 presents the baseline demographic characteristics. African American children had parents with lower educational levels and lower a household income than non-African American children (p<0.05 for both variables). Overall, ten (48 %) adolescents had systolic and/or diastolic blood pressure readings at or above the 95th percentile for their age, sex and height, the majority of whom were African American (70 vs. 30 % non-African American) ( Table 2) . There was a range of medication regimens with the most frequent regimen being a single prescription for amlodipine Table 3 .
Association between medication adherence and BP control Participants were divided into adherence groups using a median split for all measures of adherence. Individuals scoring above the MPR median had a higher prevalence of BP control than those individuals who scored below the MPR median (100 vs. 36 % with good BP control; p< 0.001) ( Fig. 1a ; systolic: p<0.01; diastolic: p<0.48). In fact, seven of the eight participants with low adherence according to the MPR had poorly controlled BP, whereas none of the eight participants with high adherence according to the MPR had poorly controlled BP (Fig. 2) . However, there were no significant differences in BP percentiles or number of participants with controlled BP between patients in the low versus high adherence groups as assessed by MEMS caps or the parent and teen self-report measure (Fig. 1b, c) .
Race comparisons
Differences in adherence and BP control were examined between African American and non-African American participants (Table 2 ). There was a significant difference in adherence measured by MPR, with African Americans more likely to have lower medication adherence than non-African Americans (mean MPR0.54 ±0.21 vs. 0.85±0.16, respectively; p<0.001). Adherence measured by the MEMS ratio also revealed African American adolescents to have lower adherence than non-African American adolescents; however, this difference did not reach statistical significance (mean MEMS ratio 0.75 ± 0.26 vs. 0.91±0.04, respectively; p=0.07). However, both African American adolescents and parents were more likely to report higher adherence on the self-report scale (p< 0.02 and p<0.04, respectively). Seven of the 11 (64 %) African American participants compared to three of the ten (30 %) nonAfrican American participants had poor BP control (p=0.18).
Discussion
This study is one of the first to examine adherence to antihypertensive medications among adolescents with hypertension. The results show that adherence to medication as measured by 1 year of pharmacy refill records correlates with BP control, but that adherence measured by 30 days of MEMs caps and by parental/teen self-report was not significantly associated with BP control. Interestingly, African American adolescents were more likely to have lower medication adherence, but there were no racial differences in BP control. Disparities in prevalence of hypertension between African American and non-African Americans have been previously reported in adults [11, 12] . African Americans are more likely to have a diagnosis of hypertension and to have worse morbidity and mortality due to poorly controlled hypertension [19] . As in our study, antihypertensive medication pharmacy refills rates have been shown to be lower for African American adults compared to white adults. Furthermore, self-reported adherence has been associated with poorer BP control [11] . Our study is one of the first to demonstrate that racial disparities in medication adherence may start as early as adolescence.
Previous research among adults with hypertension has identified a number of possible explanations for lower adherence. One of the most salient factors is medication health beliefs. Patients who perceive medications to be harmful and non-effective are more likely to be non-adherent to their prescribed medications [20] . In a large study of 806 adults seen in an urban care center for hypertension, African American adults were more likely to report non-adherence, more concerns about the medications and lower endorsement that medications are needed to manage their hypertension [15] . Other sociodemographic factors associated with medication adherence as well as BP control include income level, educational attainment, health literacy, and patientphysician communication [21] . Given that most of the identified factors associated with these racial disparities are potentially modifiable, they are likely targets for interventions to improve medication adherence and health outcomes among African Americans.
Culturally sensitive interventions are needed to improve medication adherence among African American adolescents. Adolescence is a critical window for adherence since previous research across illnesses has demonstrated that adherence declines during this age [22] . As such, earlier intervention is essential to prevent non-adherence; once this behavior is learned, it is more difficult to change. Previous research in other chronic illnesses has demonstrated that interventions need to be multilevel in order to affect the wide array of barriers to medication adherence [23] . Furthermore, clinicians need to routinely assess and discuss adherence with their patients in order to prevent worse health outcomes.
Our results did identify differences in adherence measurement according to method applied. Adherence assessed by the MPR was much lower than that assessed via the MEMS ratio. There are several possible explanations for this. The electronic monitoring period with the MEMS cap was for a limited time period of approximately 28 days. Previous research has shown that monitoring can lead to patient reactivity and increase adherence behavior [24] . Furthermore, medication adherence over time involves a complex set of behaviors that includes coordinating refills with the provider, obtaining the medication from the pharmacy, as well as taking the medication as prescribed. The MEMS cap only assesses the last step of adherence, whereas pharmacy refills may reflect all three steps. In our study, participants had to have medications in the home to participate. Therefore, one hypothesis for the seemingly contradictory results may be that many teens remember to take their medication when it is available and they know they are being observed but have difficulty coordinating refills with their parents, since they are dependent on the latter to obtain the medication from the pharmacy.
This study has several limitations that affect its generalizability. This was a pilot study examining antihypertensive medication adherence among adolescents so the results are based on a small sample size and may not represent the general population of adolescents with hypertension. Because of the small sample size, we were not able to control for other sociodemographic factors that may be associated with BP control, such as age, gender, income, and education level. We were also not able to conduct multivariable models to control for race when looking at the association between adherence and BP control. As there is no established cutoff point for adherence among adolescents, we utilized median splits based on this sample for each measure, which we acknowledge limits generalizability. Additionally, we relied on a single manual BP measurement obtained at a clinic visit. This does not take into account the variability of BP measurement. Future research should use 24-h ambulatory BP measurement as this provides a more efficient and precise assessment of BP than one set of daily conventional measurements [25, 26] . Finally, the participants included in this study were recruited from a tertiary care center and have a number of other health comorbidities, Fig. 2 Medication possession ratio by BP percentile which may affect overall treatment regimens and selfmanagement skills.
Future studies with larger samples are needed to confirm and further examine this possible link between medication non-adherence and BP control among adolescents. Identifying the role that modifiable factors, such as adherence, play on BP control is important in order to develop targeted clinical and behavioral interventions to improve BP control and reduce health disparities. Previous research among adults has identified a number of other sociodemographic variables (e.g. education level, socioeconomic status, other ethnic groups) that are also associated with hypertensive adherence and BP control. It is important that larger studies evaluate the impact of these factors on adherence and BP control in pediatric population.
Furthermore, longitudinal studies are needed to determine the impact of non-adherence on health outcomes and the potential mediating role of non-adherence to known health disparities between African American and whites. Given the advent of e-prescribing and the use of electronic medical records, pharmacy records to calculate MPRs may be more easily available. Research is needed to validate the results of this study and to understand how we can best incorporate this information into clinical care. A recent study found that when clinicians used patient pharmacy adherence data during an asthma clinical encounter and addressed non-adherence with their patients, patient adherence significantly increased; however, only a minority of clinicians used these data [27] . Therefore, more research and clinician engagement will be needed on how to use these administrative data effectively to improve patient adherence and overall health.
